SFRP1 and polycystic ovary syndrome: In addition, SFRP1, a Wnt signaling inhibitor with higher expression in the proliferative phase32, is downregulated in the stroma 1, stroma 2, stroma cycling and SMC subpopulation in women with PCOS compared with controls.